Here, we report that Syk can be expressed in high grade serous ovarian cancer and triple negative breast cancers and promotes DNA double strand break resection, homologous recombination (HR) and therapeutic resistance. The gene discussed is SYK; the disease is ovarian serous adenocarcinoma.